A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
暂无分享,去创建一个
V. Baekelandt | R. Van Elzen | M. Gérard | P. Van der Veken | J. Garcia-horsman | A. Lambeir | T. Myöhänen | P. Männistö | M. Hannula